Juvena Therapeutics

Palo Alto, United States

Juvena Therapeutics develops tissue-restorative biologics to address chronic muscle and age-related conditions.

$33.5M raised

Jan 2026

Series B

Biopharma Biotechnology Health Care Life Science

Top Investors

Alumni VenturesEli LillyMubadala CapitalFelicisLiquid 2 Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Juvena Therapeutics

How much funding has Juvena Therapeutics raised?

Juvena Therapeutics has raised $33.5M in total funding. The most recent round was Series B. The last funding was announced in January 2026.

Who are Juvena Therapeutics's investors?

Juvena Therapeutics's investors include Alumni Ventures, Eli Lilly, Mubadala Capital, Felicis, Liquid 2 Ventures.

Where is Juvena Therapeutics headquartered?

Juvena Therapeutics is headquartered in Palo Alto, United States.

What does Juvena Therapeutics do?

Juvena Therapeutics develops tissue-restorative biologics to address chronic muscle and age-related conditions.

What stage is Juvena Therapeutics at?

Juvena Therapeutics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 12, 2026.

MLA

"Juvena Therapeutics — Funding & Investors." VCBacked, January 12, 2026, https://www.vcbacked.co/company/juvena-therapeutics. Accessed June 3, 2026.

APA

VCBacked. (2026). Juvena Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/juvena-therapeutics

Wikipedia (cite web)

{{cite web |title=Juvena Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/juvena-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 12, 2026.

Similar Companies in Biopharma